CD31+/CD42b− MPs were 60% and 69% lower in both the CAD (1.19 ± 0.49 particles/μl) and the NSTEMI patients (0.94 ± 0.26 particles/μl), respectively, compared with the healthy group (2.98 ± 1.1 particles/μl; p = .02 and p = .003, respectively). The gene discussed is PECAM1; the disease is coronary artery disorder.